A. Proportion of men with Low Semen Quality (LSQ) including 95% confidence interval (CI) versus prevalence, overall and for men on medication(s) (M); B: Point estimates with 95% CI... by P.G.J. ter Horst (21743830)

Subjects:

Prevalence of low semen quality including 95% confidence interval (CI) for medication at the ATC 5 level. by P.G.J. ter Horst (21743830)

Subjects:

Univariable and multivariable analyses (age- and abstinence days-adjusted), concerning a selection of medicaments with n ≥ 10 medicament users and p < 0.1 by univariate analysis.... by P.G.J. ter Horst (21743830)

Subjects:

NASA TLX results of Task 1 for (a) low-intensity light, (b) out of vision hands and (c) self occlusion error. by Mucahit Gemici (21519313)

Flow diagram of participant selection. by Prajwal Paudel (7359209)

Subjects:

Bivariate association of characteristics of mothers (<34 weeks POG) who received and did not receive ACS. by Prajwal Paudel (7359209)

Subjects:

Supplementary file ACS. by Prajwal Paudel (7359209)

Subjects:

Multivariate analysis of the outcomes among the newborns who mothers receive or did not receive ACS. by Prajwal Paudel (7359209)

Subjects:

Bivariate analysis of morbidities among newborns whose mothers received or did not receive ACS. by Prajwal Paudel (7359209)

Subjects:

Multivariate analysis of the morbidities among the newborns who mothers receive or did not receive ACS. by Prajwal Paudel (7359209)

Subjects:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment. by Kazuyoshi Ohkawa (836847)

Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment. by Kazuyoshi Ohkawa (836847)

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment. by Kazuyoshi Ohkawa (836847)

Two magnifications SEM; (A and B) and TEM (C and D) images for the produced TiO₂ nanofibers. by Nasser A. M. Barakat (11705885)

Table 5_PABPN1 as a pan-cancer biomarker: prognostic significance and association with tumor immune microenvironment.xlsx by Hong-Xing Li (316258)

“…After down expression of PABPN1, mRNA expression levels of MRPS15 and GPx (Glutathione peroxidase) decreased significantly in T24, 5637 HLF and MCF-7 cells.…”

Image 8_PABPN1 as a pan-cancer biomarker: prognostic significance and association with tumor immune microenvironment.tif by Hong-Xing Li (316258)

“…After down expression of PABPN1, mRNA expression levels of MRPS15 and GPx (Glutathione peroxidase) decreased significantly in T24, 5637 HLF and MCF-7 cells.…”

Table 2_PABPN1 as a pan-cancer biomarker: prognostic significance and association with tumor immune microenvironment.xlsx by Hong-Xing Li (316258)

“…After down expression of PABPN1, mRNA expression levels of MRPS15 and GPx (Glutathione peroxidase) decreased significantly in T24, 5637 HLF and MCF-7 cells.…”

Image 3_PABPN1 as a pan-cancer biomarker: prognostic significance and association with tumor immune microenvironment.tif by Hong-Xing Li (316258)

“…After down expression of PABPN1, mRNA expression levels of MRPS15 and GPx (Glutathione peroxidase) decreased significantly in T24, 5637 HLF and MCF-7 cells.…”

Image 6_PABPN1 as a pan-cancer biomarker: prognostic significance and association with tumor immune microenvironment.tif by Hong-Xing Li (316258)

“…After down expression of PABPN1, mRNA expression levels of MRPS15 and GPx (Glutathione peroxidase) decreased significantly in T24, 5637 HLF and MCF-7 cells.…”

Image 7_PABPN1 as a pan-cancer biomarker: prognostic significance and association with tumor immune microenvironment.png by Hong-Xing Li (316258)

“…After down expression of PABPN1, mRNA expression levels of MRPS15 and GPx (Glutathione peroxidase) decreased significantly in T24, 5637 HLF and MCF-7 cells.…”